Merck Licenses Metathesis

Materia (Pasadena, CA) says it has licensed, on a nonexclusive basis, its metathesis technology and Grubbs catalyst system for the synthesis of pharmaceutical ingredients, to Merck & Co. Financial terms were not disclosed. The metathesis reaction is used in research and industry to develop drugs, herbicides, polymers, and...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers